Synthace raises $25.6 mln Series B

London-based Synthace Ltd, a developer of a cloud software platform for automating and improving the success rate of biological research and development, has secured $25.6 million in Series B funding. Horizons Ventures led the round with participation from other investors that included Luminous Ventures and SOSV.

North AmericaUSBriefs